Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsCurrent Deferred RevenueCurrent LeasesInventoryLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Apyx Medical (APYX) Retained Earnings (2016 - 2025)

Apyx Medical's Retained Earnings history spans 16 years, with the latest figure at -$89.1 million for Q4 2025.

  • For Q4 2025, Retained Earnings fell 14.39% year-over-year to -$89.1 million; the TTM value through Dec 2025 reached -$89.1 million, down 14.39%, while the annual FY2025 figure was -$89.1 million, 14.39% down from the prior year.
  • Retained Earnings reached -$89.1 million in Q4 2025 per APYX's latest filing, down from -$87.8 million in the prior quarter.
  • In the past five years, Retained Earnings ranged from a high of -$2.3 million in Q1 2021 to a low of -$89.1 million in Q4 2025.
  • Average Retained Earnings over 5 years is -$47.2 million, with a median of -$42.5 million recorded in 2023.
  • Peak YoY movement for Retained Earnings: tumbled 711.23% in 2022, then fell 14.39% in 2025.
  • A 5-year view of Retained Earnings shows it stood at -$12.6 million in 2021, then plummeted by 184.72% to -$35.7 million in 2022, then tumbled by 52.37% to -$54.4 million in 2023, then tumbled by 43.09% to -$77.9 million in 2024, then decreased by 14.39% to -$89.1 million in 2025.
  • Per Business Quant, the three most recent readings for APYX's Retained Earnings are -$89.1 million (Q4 2025), -$87.8 million (Q3 2025), and -$85.8 million (Q2 2025).